Clinical Trial

Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia

Study acronym: LIPIGUARD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to observe a decrease in plasma LDL cholesterol concentration of 10% (or 0.20g/L) in subjects with untreated moderate hypercholesterolemia after 3 months of consumption of the Limicol®-NG food supplement, compared with a historical placebo group
Trial Details
NCT Number NCT06894251
Lead Sponsor Institut Pasteur de Lille
Conditions Healthy Volunteer
Enrollment 35 participants
Start Date 2025-03-10
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-25